UK-US strike tariff deal on pharmaceuticals
The UK and US agree a major trade deal removing US import taxes on UK drugs for 3 years, while the NHS commits to higher spending on new medicines. Discover the impact.
Category : Search result: AstraZeneca
Queensland's Covid response lacked sense, expert says
A leading health advisor reveals Queensland's pandemic measures often lacked compassion and were driven by 'captains' calls'. Discover the inside story of the controversial lockdowns.
NHS patients may get only generic drugs, warns AstraZeneca
The CEO of pharmaceutical giant AstraZeneca warns that NHS patients may be limited to generic medicines unless the health service increases what it pays for branded drugs, raising concerns about access to cutting-edge treatments.
Reeves scraps share stamp duty after AstraZeneca warning
Chancellor Rachel Reeves scraps the outdated 0.5% stamp duty on share purchases in major U-turn, acknowledging AstraZeneca's London listing concerns. A victory for UK financial competitiveness.
AstraZeneca cuts drug prices for NHS in Trump-backed deal
Pharmaceutical giant AstraZeneca agrees to major price reductions on life-saving medications for NHS patients in unprecedented deal supported by former President Trump, promising significant savings for Britain's healthcare system.
Trump pressured AstraZeneca on US drug prices
Exclusive investigation reveals how Donald Trump pressured AstraZeneca to slash US drug prices while keeping UK costs high, exposing stark transatlantic healthcare divide.
AstraZeneca to Provide Cancer Drugs to Medicaid Patients
In a groundbreaking healthcare development, AstraZeneca announces it will provide expensive cancer medications to low-income Americans through Medicaid, challenging pharmaceutical industry norms.
Trump Claims AstraZeneca COVID Drug Discount Amid Questions
Former President Donald Trump announces dramatic price reduction for AstraZeneca's COVID-19 antibody treatment, but details remain scarce and verification proves challenging.
AstraZeneca threatens UK investment over NHS drug prices
Pharmaceutical giant AstraZeneca threatens to slash billions in UK investment unless incoming Labour government agrees to significant NHS drug price increases, creating early crisis for Keir Starmer.
AstraZeneca universal flu vaccine advances in FDA trials
A revolutionary universal flu vaccine from AstraZeneca shows remarkable potential in early trials, offering hope for long-term protection against multiple influenza strains.
AstraZeneca faces NY Medicaid exclusion in pricing clash
Pharmaceutical giant AstraZeneca could be blocked from New York's Medicaid programme following a White House meeting failure over the US paying significantly more for drugs than other nations.
AstraZeneca shifts cancer drug production from UK to Ireland
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Big Pharma's Billion-Pound Bet on Post-Trump UK
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
AstraZeneca Pauses £500m Cambridge HQ Investment
Pharmaceutical giant AstraZeneca has paused plans for its new £500 million global headquarters in Cambridge, citing an 'unfavourable' UK economic climate and sending shockwaves through the business community.
AstraZeneca Pauses £200m Cambridge Research Investment
Pharmaceutical giant AstraZeneca pauses its major £200m Cambridge research centre expansion, citing global strategic review and UK economic uncertainty in post-Brexit landscape.
AstraZeneca's Revolutionary Blood Pressure Pill Shows Promise
A groundbreaking new hypertension drug, Baxdrostat, developed by AstraZeneca, has demonstrated remarkable success in clinical trials, potentially offering new hope for millions with treatment-resistant high blood pressure in the UK.
AstraZeneca CEO warns of Trump tariffs impact
AstraZeneca's CEO highlights the critical role of the US market amid looming Trump tariffs, emphasising the need for stable trade policies to sustain pharmaceutical innovation.
AstraZeneca shares drop after US legal setback
Pharmaceutical giant AstraZeneca faces a sharp decline in share prices following an unfavourable US court ruling, sparking investor concerns.
AstraZeneca invests $1.5bn in US despite Trump tariff threats
Pharmaceutical giant AstraZeneca announces a bold $1.5bn US expansion despite looming tariff threats from the Trump administration, signalling confidence in transatlantic trade resilience.
Page 1 of 1